Status:
COMPLETED
Diphenhydramine for Acute Migraine
Lead Sponsor:
Montefiore Medical Center
Conditions:
Migraine
Eligibility:
All Genders
21-64 years
Phase:
PHASE4
Brief Summary
Parenteral diphenhydramine is commonly used as adjuvant therapy for acute migraine despite the fact that data supporting this practice do not exist. The investigators propose a randomized double blind...
Eligibility Criteria
Inclusion
- Acute migraine headache
- Present to our emergency room in the Bronx, NY for treatment of migraine headache
Exclusion
- Temperature \> 100.3 F
- Pheochromocytoma
- Seizure disorder
- Parkinson's disease
- Use of monoamine oxidase (MAO) inhibitors
- Use of anti-rejection transplant medications
- Use of potassium supplements
- Use of pramlintide
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
208 Patients enrolled
Trial Details
Trial ID
NCT01825941
Start Date
April 1 2013
End Date
December 1 2014
Last Update
July 31 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montefiore Medical Center
The Bronx, New York, United States, 10467